Cargando…

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial

BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baussano, Iacopo, Franceschi, Silvia, Gillio-Tos, Anna, Carozzi, Francesca, Confortini, Massimo, Palma, Paolo Dalla, De Lillo, Margherita, Del Mistro, Annarosa, De Marco, Laura, Naldoni, Carlo, Pierotti, Paola, Schincaglia, Patrizia, Segnan, Nereo, Zorzi, Manuel, Giorgi-Rossi, Paolo, Ronco, Guglielmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669053/
https://www.ncbi.nlm.nih.gov/pubmed/23706168
http://dx.doi.org/10.1186/1471-2334-13-238
_version_ 1782271692973801472
author Baussano, Iacopo
Franceschi, Silvia
Gillio-Tos, Anna
Carozzi, Francesca
Confortini, Massimo
Palma, Paolo Dalla
De Lillo, Margherita
Del Mistro, Annarosa
De Marco, Laura
Naldoni, Carlo
Pierotti, Paola
Schincaglia, Patrizia
Segnan, Nereo
Zorzi, Manuel
Giorgi-Rossi, Paolo
Ronco, Guglielmo
author_facet Baussano, Iacopo
Franceschi, Silvia
Gillio-Tos, Anna
Carozzi, Francesca
Confortini, Massimo
Palma, Paolo Dalla
De Lillo, Margherita
Del Mistro, Annarosa
De Marco, Laura
Naldoni, Carlo
Pierotti, Paola
Schincaglia, Patrizia
Segnan, Nereo
Zorzi, Manuel
Giorgi-Rossi, Paolo
Ronco, Guglielmo
author_sort Baussano, Iacopo
collection PubMed
description BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence in nine different areas of Northern and Central Italy by studying the women recruited in the intervention arm of the New Technologies in Cervical Cancer study and tested by Hybrid Capture 2. Differences in the age-distribution of HPV infection were investigated in each centre by the joinpoint approach in a logistic model. 46,900 women aged 25 to 60 years were included in the analysis. RESULTS: The HR-HPV age-standardised (on Italian population) prevalence ranged from 5.7% (Trento) to 10.3% (Ravenna). HR-HPV prevalence decreased as a logistic function of increasing age in 6 of 9 centres (Trento, Verona, Florence, Bologna, Imola, and Viterbo). The effect of age on HR-HPV prevalence slopes did not differ significantly among these 6 centres, whereas significant heterogeneity in intercepts (p < 0.001) was found, reflecting different overall HR-HPV prevalence between centres. One significant joinpoint was observed in 2 centres (Padua and Ravenna), indicating that the decrease in HR-HPV prevalence by age was better described using a function composed with two logistic segments. In Padua HR-HPV prevalence decreased only slightly up to 39 years but showed a steep downturn thereafter. In Ravenna HR-HPV prevalence decreased steeply down to 45 years of age and then showed a plateau. Finally, in Turin two significant joinpoints were observed: prevalence decreased only after age 29 and showed a plateau after age 39. CONCLUSIONS: Our results showed substantial differences in overall and age-specific HR-HPV prevalence across Italian areas. These findings may be related to different timing of changes in sexual behaviours across regions. Age-specific HR-HPV prevalence in Italy does not support an influence of age per se.
format Online
Article
Text
id pubmed-3669053
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36690532013-06-01 Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial Baussano, Iacopo Franceschi, Silvia Gillio-Tos, Anna Carozzi, Francesca Confortini, Massimo Palma, Paolo Dalla De Lillo, Margherita Del Mistro, Annarosa De Marco, Laura Naldoni, Carlo Pierotti, Paola Schincaglia, Patrizia Segnan, Nereo Zorzi, Manuel Giorgi-Rossi, Paolo Ronco, Guglielmo BMC Infect Dis Research Article BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence in nine different areas of Northern and Central Italy by studying the women recruited in the intervention arm of the New Technologies in Cervical Cancer study and tested by Hybrid Capture 2. Differences in the age-distribution of HPV infection were investigated in each centre by the joinpoint approach in a logistic model. 46,900 women aged 25 to 60 years were included in the analysis. RESULTS: The HR-HPV age-standardised (on Italian population) prevalence ranged from 5.7% (Trento) to 10.3% (Ravenna). HR-HPV prevalence decreased as a logistic function of increasing age in 6 of 9 centres (Trento, Verona, Florence, Bologna, Imola, and Viterbo). The effect of age on HR-HPV prevalence slopes did not differ significantly among these 6 centres, whereas significant heterogeneity in intercepts (p < 0.001) was found, reflecting different overall HR-HPV prevalence between centres. One significant joinpoint was observed in 2 centres (Padua and Ravenna), indicating that the decrease in HR-HPV prevalence by age was better described using a function composed with two logistic segments. In Padua HR-HPV prevalence decreased only slightly up to 39 years but showed a steep downturn thereafter. In Ravenna HR-HPV prevalence decreased steeply down to 45 years of age and then showed a plateau. Finally, in Turin two significant joinpoints were observed: prevalence decreased only after age 29 and showed a plateau after age 39. CONCLUSIONS: Our results showed substantial differences in overall and age-specific HR-HPV prevalence across Italian areas. These findings may be related to different timing of changes in sexual behaviours across regions. Age-specific HR-HPV prevalence in Italy does not support an influence of age per se. BioMed Central 2013-05-24 /pmc/articles/PMC3669053/ /pubmed/23706168 http://dx.doi.org/10.1186/1471-2334-13-238 Text en Copyright © 2013 Baussano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Baussano, Iacopo
Franceschi, Silvia
Gillio-Tos, Anna
Carozzi, Francesca
Confortini, Massimo
Palma, Paolo Dalla
De Lillo, Margherita
Del Mistro, Annarosa
De Marco, Laura
Naldoni, Carlo
Pierotti, Paola
Schincaglia, Patrizia
Segnan, Nereo
Zorzi, Manuel
Giorgi-Rossi, Paolo
Ronco, Guglielmo
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title_full Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title_fullStr Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title_full_unstemmed Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title_short Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
title_sort difference in overall and age-specific prevalence of high-risk human papillomavirus infection in italy: evidence from ntcc trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669053/
https://www.ncbi.nlm.nih.gov/pubmed/23706168
http://dx.doi.org/10.1186/1471-2334-13-238
work_keys_str_mv AT baussanoiacopo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT franceschisilvia differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT gilliotosanna differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT carozzifrancesca differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT confortinimassimo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT palmapaolodalla differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT delillomargherita differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT delmistroannarosa differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT demarcolaura differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT naldonicarlo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT pierottipaola differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT schincagliapatrizia differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT segnannereo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT zorzimanuel differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT giorgirossipaolo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial
AT roncoguglielmo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial